Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.4%
    Check dated 2024-12-14T22:56:20.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T16:30:02.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Several links related to leukemia, organ donation, and stem cells have been removed, indicating a significant reduction in available resources on these topics.
    Difference
    4%
    Check dated 2024-11-23T04:59:26.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    New resources have been added related to leukemia, organ donation, and stem cells, including links to MedlinePlus and NIH, which may be of particular interest to users seeking information on these topics.
    Difference
    1%
    Check dated 2024-11-16T00:23:33.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the option to show less content.
    Difference
    5%
    Check dated 2024-11-08T18:40:46.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.7%
    Check dated 2024-11-01T11:05:42.000Z thumbnail image

Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.